human liver derived cell line hepg2 (Procell Inc)
Structured Review

Human Liver Derived Cell Line Hepg2, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human liver derived cell line hepg2/product/Procell Inc
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Hyperimonates A and B, a pair of unprecedented polyprenylated acylphloroglucinols from Hypericum monogynum : Structural elucidation, total synthesis, and lipid-lowering activity"
Article Title: Hyperimonates A and B, a pair of unprecedented polyprenylated acylphloroglucinols from Hypericum monogynum : Structural elucidation, total synthesis, and lipid-lowering activity
Journal: Acta Pharmaceutica Sinica. B
doi: 10.1016/j.apsb.2025.10.008
Figure Legend Snippet: Effects of compounds 1 and 2 on lipid accumulation in OA/Fr-induced HepG2 cells. (A–D) Effects of compounds 1 and 2 on the accumulation of TG in OA/Fr-induced HepG2 cells and their toxicity. (E, F) Lipid accumulation was observed for com. 1 with ORO staining. Results are expressed as the mean ± standard deviations (SD) ( n = 3), scale bar = 100 μm ## P < 0.01 and ### P < 0.001 compared with the control group; ∗∗ P < 0.01 and ∗∗∗ P < 0.001 compared with the model group.
Techniques Used: Staining, Control
Figure Legend Snippet: The mechanistic study of compound 1 on the lipid accumulation in HepG2 cells. (A–F) Proteomic study when treated with 1 . (A) Principal component analysis (PCA). (B) Model (M) vs . control (CN) differentially expressed proteins (DEPs) volcano diagram. (C) Com. 1 vs . M DEPs volcano diagram. (D) DEPs between M and CN group, as well as com. 1 and M. group. (E) Clustering heat map of differential protein expression in the three groups. (F) KEGG pathway enrichment analysis.
Techniques Used: Control, Expressing
Figure Legend Snippet: Effect of compound 1 on the expression levels of proteins in OA/Fro-induced HepG2 cells. (A, G) The expression levels of proteins were analyzed by Western blot in OA/Fro-induced HepG2 cells after treatment with compound 1 for 48 h. (B–F, H–M) Schematic diagram showing the mechanism of the protective effect of compound 1 on lipid metabolism disorder. Results are expressed as the mean ± SD ( n = 3). # P < 0.05, ## P < 0.01 and ### P < 0.001 compared with the control group; ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001 compared with the model group.
Techniques Used: Expressing, Western Blot, Control
